Semiannual Securities Report — FY2026 H1
What Fureasu Co.,Ltd. reported for the period from 2026-04-01 to 2027-03-31.
During the interim consolidated accounting period, revenue was significantly below the same period of the previous year due to the impact of the transfer of the medical care facility business, while operating profit and ordinary profit exceeded the previous-year period, owing to the elimination of losses related to the transfer and a reduction in company-wide expenses. In addition, measures to improve employee compensation, including higher wage levels, were implemented to recruit and retain personnel who support home-based care, and the impact of the revised medical and nursing care fees for treatment services from 1 July 2026 (revision rate: +0.60%) is also reflected in performance.
Komori's summary of this document, not the document's own words.